Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Christine Garcia

Thoracic Oncology · NYP Weill Cornell

View

Dr. Mark Jeng

Thoracic Oncology · MSK

View

Dr. Timothy Ellis-Caleo

Thoracic Oncology · SU

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Pavlos Msaouel

GU Oncology · MD Anderson Cancer Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    KMDr. Kristen Marrone

    Dr. Kristen Marrone

    Hematology & Oncology · Thoracic Oncology
    Johns Hopkins Medicine
    kristenm

    Research

    Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer

    2026

    Via Cancer Res Commun

    Research

    Multiple Chapters, One Career: Using Career Development Plans to Find Success and Satisfaction in Academic Oncology Across the Career Spectrum

    2026

    Via Am Soc Clin Oncol Educ Book

    Research

    Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study

    2026

    Via Clin Cancer Res

    Research

    Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3

    2026

    Via J Clin Oncol

    Research

    Osimertinib plus Gefitinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD

    2026

    Via Clin Cancer Res

    Research

    Educational Priorities in Oncologic Critical Care: A Modified Delphi Study

    2026

    Via ATS Sch

    Research

    Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis

    2025

    Via JTO Clin Res Rep

    Research

    Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade

    2025

    Via Clin Cancer Res

    Research

    Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

    2025

    Via Nature

    Research

    Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis

    2025

    Via Lung Cancer

    Research

    Discovery of Methylated DNA Biomarkers for Potential Nonendoscopic Detection of Barrett's Esophagus and Esophageal Adenocarcinoma

    2025

    Via Am J Gastroenterol

    Research

    Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report

    2025

    Via J Thorac Oncol

    Research

    Primary resistance to ICI-based regimens is associated with early longitudinal changes in the fecal microbiome and loss of microbial stability

    2025

    Via medRxiv

    Research

    Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases

    2025

    Via J Neurooncol

    Research

    Characteristics of Short-Term Survivors With ALK or ROS1-Altered Metastatic NSCLC

    2025

    Via JTO Clin Res Rep